Audience: Government

Learn more about The Center for Data Driven Discovery in Biomedicine (D³b)’s commitment to the White House Precision Medicine Initiative and Cancer Moonshot 2020.  D³b brings together institutions and stakeholders from all over the world to improve care and therapeutics for children diagnosed with pediatric cancers.

First-of-its-Kind Open-Analysis Platform for Pediatric Brain Tumors Provides Robust Data Resource for Childhood Cancer Research

– Collaboration among CHOP, Alex’s Lemonade Stand Foundation, the Pacific Pediatric Neuro-Oncology Consortium, and Children’s Brain Tumor Network paves the way for new collaborative models to accelerate discoveries…

CHOP-led Pediatric Hospital Network Receives Critical Government Support for Genetic Research of Pediatric Tumors

Project will allow thousands of tissue samples to be studied and provide an enormous level of insight into childhood cancer PHILADELPHIA, November 2, 2021 – Unlocking the genetic mysteries…

Hack-a-thon Reveals Unexpected Collaboration with Airline Industry

This article was originally published on Wednesday, October 27 as a guest blog entry in Cornerstone, a publication of the Children’s Hospital of Philadelphia’s Research Institute. Editor’s Note: Since its…

NF2 Biosolutions

Background Neurofibromatosis 2 (NF2) is a rare genetic disorder that is primarily characterized by noncancerous (benign) tumors of the nerves that transmit balance and sound impulses from the…

Chordoma Foundation Biobank

Background The Chordoma Foundation (CF) biospecimens, clinical and genomic data via the expertise and tools created by the Center for Data Driven Discovery (D3b) at the Children’s Hospital…

Oligo Nation

Oligodendroglioma Oligodendroglioma (Oligo) is a primary malignant brain cancer that develops from Oligodendrocytes. Oligodendroglioma is one of the more common types of glioma (which also includes Glioblastoma Multiforme…